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Purpose: Entamoeba gingivalis (E. gingivalis) is one of the members of the wide range of oral 
resident pathogens in humans, particularly found in dental plaques, surfaces of gingiva or teeth, 
interdental spaces and carious lesions. The purpose of the current review and meta-analysis was to 
determine the global prevalence of E. gingivalis infection and its association with oral diseases 
based on published literatures. 
Materials and methods: Multiple English databases (PubMed, Scopus, Science Direct, Web of 
Science and Google Scholar) were explored for papers published until August 2020. A total of 52 
studies (including 7596 participants) met the inclusion criteria. 
Results: The overall prevalence of E. gingivalis was estimated to be 37% (95% CI 29-46%). With 
regard to different countries, the highest and lowest pooled prevalence of E. gingivalis infection 
were related to Jordan with 87% (95% CI 81-92%) and Portugal with 3% (95% CI 0-10%), 
respectively. Based on WHO regions, the highest prevalence was related to the region of the 
Americas with 56% (95% CI 31-79%). The infection was most prevalent in 46-55 mean age groups 
[61% (95% CI 21-94%)]. Among different diagnostic methods, the highest rate of the pooled 
prevalence was related to the molecular [53% (95% CI 24-81%)] and the direct methods [36% 
(95% CI 25-47%)], respectively. Our analyses revealed that E. gingivalis infection was associated 
with 4.34-fold increased risk of oral diseases (P < 0.05). 
Conclusion: Our findings revealed a high prevalence rate of the infection among periodontal 
disease patients with 37% (95% CI 20-57%). To conclude, it must be considered that E. gingivalis 
can be a risk factor associated with oral diseases and a wide range of research is needed to specify 
its role in the pathogenesis of these disorders. 
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